http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0a07856e1be95e2203a8e5fb6718bf9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Wu |
| name | Xinqi Wu |
| given-name | Xinqi |
| organization-name | Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230000, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230032, China; Collaborative Innovation Centre of Neuropsychiatric Disorder and Mental Health, Hefei 230000, China 1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 2Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: 1Department of Medical Oncology, 2Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School; and 3Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Department of Medical Oncology, 2Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School; and 3Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts Authors' Affiliations 1Immune Monitoring Core, Immunology Program, Ludwig Center for Cancer Immunotherapy; Departments of 2Medicine and 3Epidemiology and Biostatistics, Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University, New York, New York; 5Department of Medical Oncology, 6Center for Immuno-oncology, and 7Melanoma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations 1Immune Monitoring Core, Immunology Program, Ludwig Center for Cancer Immunotherapy; Departments of 2Medicine and 3Epidemiology and Biostatistics, Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University, New York, New York; 5Department of Medical Oncology, 6Center for Immuno-oncology, and 7Melanoma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations 1Immune Monitoring Core, Immunology Program, Ludwig Center for Cancer Immunotherapy; Departments of 2Medicine and 3Epidemiology and Biostatistics, Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University, New York, New York; 5Department of Medical Oncology, 6Center for Immuno-oncology, and 7Melanoma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Division of Women's Health, Departments of Medicine and of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts 02115; and Authors' Affiliations: Departments of 1Medical Oncology, From the Department of Medicine, Division of Newborn Medicine, Children’s Hospital Boston and Harvard Medical School, Boston, Mass. 1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 2Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 3Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. |
Incoming Links
Total number of triples: 39.